GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells
- PMID: 37610461
- DOI: 10.1007/s00210-023-02668-2
GPX2 acts as an oncogene and cudraflavone C has an anti-tumor effect by suppressing GPX2-dependent Wnt/β-catenin pathway in colorectal cancer cells
Abstract
Colorectal carcinoma (CRC) is a common cancer associated with poor prognosis, and cudraflavone C (Cud C) is a natural flavonol with reported anti-CRC capacity. However, the precise mechanisms underlying the anti-CRC effect require further demonstration. The aim of present study was to evaluate the impact of Cud C on the cell viability and apoptosis of CRC cells and to determine the underlying mechanisms. The Human Protein Atlas (THPA) and Gene Expression Profiling Interactive Analysis (GEPIA) databases were used to analyze the expression status of glutathione peroxidase 2 (GPX2) in CRC. Cell viability was examined using cell counting kit-8 (CCK-8) assay. Flow cytometry was utilized to evaluate apoptosis. The levels of gene transcription and protein expression of GPX2, caspase-3, cleaved caspase-3), β-catenin, and c-Myc were determined by RT-qPCR and Western blotting. Our results showed that GPX2 was overexpressed in CRC as compared to normal tissue and the extent of GPX2 overexpression is greatest in CRC when compared with other cancers according to GEPIA and THPA databases. GPX2 knockdown significantly suppressed the cell viability, induced apoptosis of CRC cell lines, and restrained the activity of Wnt/β-catenin pathway. Cud C treatment decreased cell viability, induced apoptosis in CRC cell lines, and diminished the expression level of GPX2-dependent activation of Wnt/β-catenin pathway, while such effects can be abolished by GPX2 overexpression. In conclusion, Cud C suppressed GPX2-dependent Wnt/β-catenin pathway to exert anti-CRC function.
Keywords: Apoptosis; Colorectal carcinoma; Cudraflavone C; GPX2; Viability; Wnt/β-catenin pathway.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Arung E, Yoshikawa K, Shimizu K, Kondo R (2010) Isoprenoid-substituted flavonoids from wood of Artocarpus heterophyllus on B16 melanoma cells: cytotoxicity and structural criteria. Fitoterapia 81(2):120–123. https://doi.org/10.1016/j.fitote.2009.08.001 - DOI - PubMed
-
- Bahrami Y, Bouk S, Kakaei E, Taheri M (2022) Natural products from actinobacteria as a potential source of new therapies against colorectal cancer: a review. Front Pharmacol 13:929161. https://doi.org/10.3389/fphar.2022.929161 - DOI - PubMed - PMC
-
- Bordonaro M (2013) Crosstalk between Wnt signaling and RNA processing in colorectal cancer. J Cancer 4(2):96–103. https://doi.org/10.7150/jca.5470 - DOI - PubMed - PMC
-
- Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13(8):790–801. https://doi.org/10.1016/s1470-2045(12)70211-5 - DOI - PubMed
-
- Brigelius-Flohe R, Flohe L (2020) Regulatory phenomena in the glutathione peroxidase superfamily. Antioxid Redox Signal 33(7):498–516. https://doi.org/10.1089/ars.2019.7905 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
